133 related articles for article (PubMed ID: 38131423)
1. Combined gastric and colorectal cancer endoscopic screening may be cost-effective in Europe with the implementation of artificial intelligence: an economic evaluation.
Libanio D; Antonelli G; Marijnissen F; Spaander MC; Hassan C; Dinis-Ribeiro M; Areia M
Eur J Gastroenterol Hepatol; 2024 Feb; 36(2):155-161. PubMed ID: 38131423
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of artificial intelligence for screening colonoscopy: a modelling study.
Areia M; Mori Y; Correale L; Repici A; Bretthauer M; Sharma P; Taveira F; Spadaccini M; Antonelli G; Ebigbo A; Kudo SE; Arribas J; Barua I; Kaminski MF; Messmann H; Rex DK; Dinis-Ribeiro M; Hassan C
Lancet Digit Health; 2022 Jun; 4(6):e436-e444. PubMed ID: 35430151
[TBL] [Abstract][Full Text] [Related]
3. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk.
Areia M; Spaander MC; Kuipers EJ; Dinis-Ribeiro M
United European Gastroenterol J; 2018 Mar; 6(2):192-202. PubMed ID: 29511549
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility analysis of colonoscopy or faecal immunochemical test for population-based organised colorectal cancer screening.
Areia M; Fuccio L; Hassan C; Dekker E; Dias-Pereira A; Dinis-Ribeiro M
United European Gastroenterol J; 2019 Feb; 7(1):105-113. PubMed ID: 30788122
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test.
Senore C; Hassan C; Regge D; Pagano E; Iussich G; Correale L; Segnan N
J Med Screen; 2019 Jun; 26(2):76-83. PubMed ID: 30180780
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
[TBL] [Abstract][Full Text] [Related]
8. Colonoscopy surveillance following adenoma removal to reduce the risk of colorectal cancer: a retrospective cohort study.
Cross AJ; Robbins EC; Pack K; Stenson I; Kirby PL; Patel B; Rutter MD; Veitch AM; Saunders BP; Little M; Gray A; Duffy SW; Wooldrage K
Health Technol Assess; 2022 May; 26(26):1-156. PubMed ID: 35635015
[TBL] [Abstract][Full Text] [Related]
9. Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.
Wang ZH; Gao QY; Fang JY
Asian Pac J Cancer Prev; 2012; 13(5):1761-6. PubMed ID: 22901118
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of using artificial intelligence versus polygenic risk score to guide breast cancer screening.
Mital S; Nguyen HV
BMC Cancer; 2022 May; 22(1):501. PubMed ID: 35524200
[TBL] [Abstract][Full Text] [Related]
12. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
14. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
15. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China.
Xia R; Zeng H; Liu W; Xie L; Shen M; Li P; Li H; Wei W; Chen W; Zhuang G
JAMA Netw Open; 2021 Aug; 4(8):e2121403. PubMed ID: 34402889
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of real-time artificial intelligence-assisted colonoscopy in Italy.
Hassan C; Povero M; Pradelli L; Spadaccini M; Repici A
Endosc Int Open; 2023 Nov; 11(11):E1046-E1055. PubMed ID: 37954109
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
20. The Effectiveness of Screening Total Colonoscopy for Preoperative Patients with Gastric Cancer.
Koseki Y; Hikage M; Terashima M; Notsu A; Furukawa K; Fujiya K; Tanizawa Y; Takada K; Imai K; Shiomi A; Bando E
Ann Surg Oncol; 2024 Feb; 31(2):762-771. PubMed ID: 37925659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
